Helixgate https://validator.w3.org/feed/docs/rss2.html Ancient Peptides Resurrected from Lactoferrin’s Evolutionary Past Could Point to New Antibiotics Vitruvias vanishes amid thyroid tablets recall over potential ‘superpotency’ concerns Kennedy posts vaccine misinformation, spars on social media amid measles deaths Revolution drug heralded as a pancreatic cancer breakthrough cleared by FDA STAT+: Former Stanford president releases emails to rebut fraud and cover-up allegations in new book Spyre tumbles as immune drug misses mark in rheumatoid arthritis STAT+: CMS plans launch event for ACCESS, the Medicare chronic care pilot Michael Polansky has a new, skin-focused biotech. Don’t call it a drug company. Generate Bio drops as data accidentally leaked ahead of European conference RevMed could become ‘next oncology titan’ with Rasonque nod AstraZeneca, Amgen notch another late-stage win for Tezspire, this time in esophagitis Fragile X at a turning point: Breaking through the clinical bottleneck Nearly 1/4 dealing with long-term unemployment call it quits on biopharma job searches Myotis Bat Genomes Reveal How They Fight Viruses, Cancer, and Cellular Damage The great disconnect: 4 ways companies, job candidates misalign Myriad catalysts on deck for obesity’s brightest stars as market continues to accelerate RevMed receives early FDA approval for ‘groundbreaking’ pancreatic cancer drug Summit, Akeso tout biliary cancer win for PD-1/VEGF in China—but details are pending CAR Ts will only treat autoimmune diseases if we can scale delivery BMS ends Cellares pact over cell therapy production problems, triggering layoffs Biohaven could get up to $795M in epilepsy alliance with SK Bio 2026 IPO stock tracker: How newly public biotechs are performing Jazz scores front-line gastric cancer nod from FDA for ‘practice-changing’ Ziihera Weight-loss pill may quiet alcohol cravings Capricor’s DMD therapy still alive, Merck/Moderna’s cancer vax shines, FDA’s future revealed CDMO hiring tough as demand for specialized talent outpaces supply Inside the Gulf biotech deal model, ahead of RGMBS 2026 in Riyadh Automated prototyping of genetic codes New Jazz cancer drug approval could drive blockbuster sales STAT+: Sword Health to acquire Headspace, according to filing In Massachusetts, Latest Annual Snapshot Shows a Tale of Two Biopharmas Roche, Eli Lilly get FDA nod for new Alzheimer’s blood test Pennsylvania reports first 2 measles deaths in the U.S. this year, both people unvaccinated Expanded Synthetic Promoter Library Introduced to Boost Biomanufacturing Operations STAT+: How Trump’s funding cuts are reshaping the health system Biotech IPOs approach ‘escape velocity’ barring yellow flags that could threaten rebound China’s Haisco forms immunology biotech with up to $1.5B from American VCs New drug displays anti-inflammatory and neuroprotective effects in ALS Bausch + Lomb advances dry eye disease drug to Phase 3 despite mid-stage fail Labcorp launches new hepatitis D test to find patients with most severe form of virus Lilly takes oral obesity race abroad with UK launch of Foundayo Massachusetts biopharma jobs, including R&D positions, fell in 2025: Report NASA finds Earth microbes could survive on the Moon Preparing for Novartis showdown, Curium touts value of radiopharma supply resiliency UCSF QBI Awarded $46M to Translate Landmark Autism Map Into Precision Therapies Young startups miss out on biotech venture funding rebound, MassBio says Predictive design of tissue-specific mammalian enhancers that function in the mouse embryo Transferable genetic toolsets for nonmodel gut Clostridia enable in vivo reversible control of metabolite production Helixgate AI & Biotech Collaboration Series + Helixgate Industry Nights Home